Nuvectis Pharma Inc

Market Cap

$619M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$19.59+$11.08 (+130.20%)

Jul 15, 2026

52W High $28.5352W Low $5.65

Company Details

Nuvectis Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious conditions of unmet medical need in oncology. The company is developing NXP900, a small molecu...

Leadership

Ron Bentsur M.B.A.Founder

Co-Founder, Chairman, CEO & President

Enrique Poradosu Ph.D.Founder

Co-Founder, Executive VP, Chief Scientific & Business Officer

Shay ShemeshFounder

Co-Founder, Executive VP, Chief Development & Operations Officer

Michael Carson CPA

Vice President of Finance

IPO Date

Feb 4, 2022

Website

www.nuvectis.com

Key Metrics TTM

Revenue

-100.0% YoY

Net Income

-$27M

EPS (Diluted)

Free Cash Flow

-$18M

Revenue / Share

$0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Revenue & Profitability

Valuation

Operating Cash Flow

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee